Spark Investment Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Spark Investment Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,220	Closed	-$299K	–	577
2019 Q4	$299K	Sell	9,220 -8,092	-47%	-$251K	0.04%	401
2019 Q3	$450K	Buy	17,312 +7,569	+78%	+$253K	0.06%	261
2019 Q2	$357K	Hold	9,743	–	–	0.02%	403
2019 Q1	$215K	Sell	9,743 -3,557	-27%	-$62.2K	0.01%	490
2018 Q4	$187K	Buy	+13,300	New	+$207K	0.01%	506

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Spark Investment Management's ODT Position: Q1 2020 in Review

Spark Investment Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2020, closing a stake of 9,220 shares — an estimated $299K sold.

Spark Investment Management first reported a position in ODT in Q4 2018 and held it in 5 quarters. The position peaked at $450K in Q3 2019. 78 funds tracked by Wall St. Rank hold ODT as of Q1 2020.

Spark Investment Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 9,220 Odonate Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $299K.
Spark Investment Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
Spark Investment Management's Odonate Therapeutics, Inc. Common Stock position peaked at $450K in Q3 2019.
78 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.